Market Place
Sourcing Support
Lucy Achieves Milestone with Completion of Acquisition of Assets of Wesana
05 Jul 2023 //
GLOBENEWSWIRE
Wesana Health Announces Closing of Previously Announced SANA-013 Asset Sale
05 Jul 2023 //
GLOBENEWSWIRE
Wesana Health Announces Sale of SANA-13 Assets to Lucy Scientific Discovery
21 Mar 2023 //
GLOBENEWSWIRE
Wesana Health Announces Receipt of Short-Term Loan
16 Dec 2022 //
GLOBENEWSWIRE
Wesana Announces Sale of Clinic Management Services Organization
01 Sep 2022 //
GLOBENEWSWIRE
Wesana Announces Second Quarter 2022 Financial Results
29 Aug 2022 //
GLOBENEWSWIRE
Wesana Health CEO Daniel Carcillo to Keynote Charles River Symposium
08 Jun 2022 //
GLOBENEWSWIRE
Wesana Announces First Quarter 2022 Financial Results
31 May 2022 //
GLOBENEWSWIRE
Wesana Health Outlines Accelerated Drug Development Pathway
10 May 2022 //
GLOBENEWSWIRE
Wesana Announces Singular Focus on Drug Development
05 May 2022 //
GLOBENEWSWIRE
Wesana Health Reports Q4 2021 Financial Results
02 May 2022 //
GLOBENEWSWIRE
Wesana Is Exploring Broadening SANA-013 Lead Indication to Treat MDD
18 Apr 2022 //
GLOBENEWSWIRE
Wesana Health Announces New Findings Indicating Psilocybin
22 Mar 2022 //
GLOBENEWSWIRE
Wesana Health Shows Positive Feedback From Pre-IND Meeting With FDA on SANA-013
14 Mar 2022 //
GLOBENEWSWIRE
Wesana Provides Updates on Build-out of Third Clinic
11 Mar 2022 //
GLOBENEWSWIRE
Wesana Health Provides Strategic and Operational Updates
12 Jan 2022 //
GLOBENEWSWIRE
Wesana Completes Filing of PCT Patents for Novel Drug Protocols
09 Dec 2021 //
GLOBENEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.